Pulmonary diseases and the liver

Clinics in Liver Disease

Volumn 15, Issue 1, 2011, Pages 21-37

  Kochar, Rajan ^a   Fallon, Michael B ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

1 Antitrypsin; Cystic fibrosis; Hepatic sarcoidosis; Hepatic tuberculosis; Hypoxic hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA 1 ANTITRYPSIN; ASPARTATE AMINOTRANSFERASE; ETHAMBUTOL; ISONIAZID; LIVER ENZYME; PYRAZINAMIDE; RIFAMPICIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ABDOMINAL PAIN; ABNORMAL LABORATORY RESULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ANOREXIA; ARTERIAL OXYGEN SATURATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIARY CIRRHOSIS; BLOOD OXYGEN TENSION; CHOLELITHIASIS; CHOLESTASIS; COMMON BILE DUCT STENOSIS; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DYSPNEA; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FATIGUE; FATTY LIVER; FOCAL BILIARY CIRRHOSIS; GENE MUTATION; GENETIC RISK; HEART INDEX; HEMODYNAMICS; HEPATITIS; HEPATOBILIARY DISEASE; HEPATOBILIARY TUBERCULOSIS; HEPATOGRAPHY; HEPATOMEGALY; HYPOXIC HEPATITIS; ISCHEMIC HEPATITIS; JAUNDICE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LUNG DISEASE; LUNG FIBROSIS; LUNG SARCOIDOSIS; MEAN ARTERIAL PRESSURE; MILIARY TUBERCULOSIS; NONALCOHOLIC FATTY LIVER; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; PORTAL HYPERTENSION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; RESPIRATORY FAILURE; REVIEW; TUBERCULOSIS; WEAKNESS;

BILE DUCT DISEASES; HUMANS; LIVER DISEASES; LUNG DISEASES;

EID: 78649500643     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2010.09.005     Document Type: Review

References (92)

1. Birrer R., Takuda Y., Takara T. Hypoxic hepatopathy: pathophysiology and prognosis. Intern Med 2007, 46(14):1063-1070.
2. Bynum T.E., Boitnott J.K., Maddrey W.C. Ischemic hepatitis. Dig Dis Sci 1979, 24(2):129-135.
3. Arcidi J.M., Moore G.W., Hutchins G.M. Hepatic morphology in cardiac dysfunction: a clinicopathologic study of 1000 subjects at autopsy. Am J Pathol 1981, 104(2):159-166.
4. Henrion J., Schapira M., Luwaert R., et al. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore) 2003, 82(6):392-406.
5. Henrion J., Minette P., Colin L., et al. Hypoxic hepatitis caused by acute exacerbation of chronic respiratory failure: a case-controlled, hemodynamic study of 17 consecutive cases. Hepatology 1999, 29(2):427-433.
6. Henrion J., Colin L., Schapira M., et al. Hypoxic hepatitis caused by severe hypoxemia from obstructive sleep apnea. J Clin Gastroenterol 1997, 24(4):245-249.
7. Ebert E.C. Hypoxic liver injury. Mayo Clin Proc 2006, 81(9):1232-1236.
8. Sveger T. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976, 294(24):1316-1321.
9. de Serres F.J. Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest 2002, 122(5):1818-1829.
10. Carlson J.A., Rogers B.B., Sifers R.N., et al. Multiple tissues express alpha 1-antitrypsin in transgenic mice and man. J Clin Invest 1988, 82(1):26-36.
11. Black L.F., Kueppers F. Alpha1-antitrypsin deficiency in nonsmokers. Am Rev Respir Dis 1978, 117(3):421-428.
12. Volpert D., Molleston J.P., Perlmutter D.H. Alpha1-antitrypsin deficiency-associated liver disease progresses slowly in some children. J Pediatr Gastroenterol Nutr 2000, 31(3):258-263.
13. DeMeo D.L., Silverman E.K. Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax 2004, 59(3):259-264.
14. Cox D.W., Billingsley G.D. Rare deficiency types of alpha 1-antitrypsin: electrophoretic variation and DNA haplotypes. Am J Hum Genet 1989, 44(6):844-854.
15. Vennarecci G., Gunson B.K., Ismail T., et al. Transplantation for end stage liver disease related to alpha 1 antitrypsin. Transplantation 1996, 61(10):1488-1495.
16. Primhak R.A., Tanner M.S. Alpha-1 antitrypsin deficiency. Arch Dis Child 2001, 85(1):2-5.
17. Mahadeva R., Chang W.S., Dafforn T.R., et al. Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis. J Clin Invest 1999, 103(7):999-1006.
18. Perlmutter D.H. Clinical manifestations of alpha-1-antitrypsin deficiency. Gastroenterol Clin North Am Part II 1995, 24:27-43.
19. Sveger T. The natural history of liver disease in alpha 1-antitrypsin deficient children. Acta Paediatr Scand 1988, 77(6):847-851.
20. Sveger T., Eriksson S. The liver in adolescents with alpha 1-antitrypsin deficiency. Hepatology 1995, 22(2):514-517.
21. Eriksson S., Carlson J., Velez R. Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med 1986, 314(12):736-739.
22. Bowlus C.L., Willner I., Zern M.A., et al. Factors associated with advanced liver disease in adults with alpha-1 antitrypsin deficiency. Clin Gastroenterol Hepatol 2005, 3(4):390-396.
23. Eriksson S. Alpha 1-antitrypsin deficiency and liver cirrhosis in adults. An analysis of 35 Swedish autopsied cases. Acta Med Scand 1987, 221(5):461-467.
24. Zhou H., Fischer H.P. Liver carcinoma in PiZ alpha-1-antitrypsin deficiency. Am J Surg Pathol 1998, 22(6):742-748.
25. Zhou H., Ortiz-Pallardó M.E., Ko Y., et al. Is heterozygous alpha-1-antitrypsin deficiency type PIZ a risk factor for primary liver carcinoma?. Cancer 2000, 88(12):2668-2676.
26. Rudnick D.A., Liao Y., An J.K., et al. Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency. Hepatology 2004, 39(4):1048-1055.
27. Rudnick D.A., Perlmutter D.H. Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in genetic liver disease. Hepatology 2005, 42(3):514-521.
28. Gordon R.D., Shaw B.W., Iwatsuki S., et al. Indications for liver transplantation in the cyclosporine era. Surg Clin North Am 1986, 66(3):541-556.
29. Prachalias A.A., Kalife M., Francavilla R., et al. Liver transplantation for alpha-1 antitrypsin deficiency in children. Transpl Int 2000, 13(3):207-210.
30. Hood J.M., Koep L.J., Peters R.L., et al. Liver transplantation for advanced liver disease with alpha-1 antitrypsin deficiency. N Engl J Med 1980, 302(5):272-275.
31. Zhang K.Y., Tung B.Y., Kowdley K.V. Liver transplantation for metabolic liver diseases. Clin Liver Dis 2007, 11(2):265-281.
32. Rowe S.M., Miller S., Sorscher E.J. Cystic fibrosis. N Engl J Med 2005, 352:1992-2001.
33. Mehta A. CFTR: more than just a chloride channel. Pediatr Pulmonol 2005, 39:292-298.
34. Sokol R.J., Durie P.R. Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group. J Pediatr Gastroenterol Nutr 1999, 28:S1-S13.
35. Feranchak A.P., Sokol R.J. Cholangiocyte biology and cystic fibrosis liver disease. Semin Liver Dis 2001, 21(4):471-488.
36. Lewindon P.J., Pereira T.N., Hoskins A.C., et al. The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease. Am J Pathol 2002, 160(5):1705-1715.
37. Nagel R.A., Westaby D., Javaid A., et al. Liver disease and bile duct abnormalities in adults with cystic fibrosis. Lancet 1989, 2(8677):1422-1425.
38. Colombo C., Apostolo M.G., Ferrari M., et al. Analysis of risk factors for the development of liver disease associated with cystic fibrosis. J Pediatr 1994, 124:393-399.
39. Wilschanski M., Rivlin J., Cohen S., et al. Clinical and genetic risk factors for cystic fibrosis-related liver disease. Pediatrics 1999, 103(1):52-57.
40. Colombo C., Battezzati P.M., Crosignani A., et al. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome. Hepatology 2002, 36(6):1374-1382.
41. Corbett K., Kelleher S., Rowland M., et al. Cystic fibrosis-associated liver disease: a population-based study. J Pediatr 2004, 145(3):327-332.
42. Colombo C., Russo M.C., Zazzeron L., et al. Liver disease in cystic fibrosis. J Pediatr Gastroenterol Nutr 2006, 43(Suppl 1):S49-S55.
43. Moyer K., Balistreri W. Hepatobiliary disease in patients with cystic fibrosis. Curr Opin Gastroenterol 2009, 25(3):272-278.
44. Layden T.J., Kulik L. Hepatic manifestations of pulmonary diseases. Clin Liver Dis 2002, 6(4):969-979. ix.
45. Wilschanski M. Patterns of gastrointestinal disease associated with mutations of CFTR. Curr Gastroenterol Rep 2008, 10(3):316-323.
46. Colombo C., Battezzati P.M., Podda M. Hepatobiliary disease in cystic fibrosis. Semin Liver Dis 1994, 14:259-269.
47. Hodson M.E., Simmonds N.J., Warwick W.J., et al. An international/multicentre report on patients with cystic fibrosis (CF) over the age of 40 years. J Cyst Fibros 2008, 7:537-542.
48. Desmond C.P., Wilson J., Bailey M., et al. The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid. Liver Int 2007, 27(10):1402-1408.
49. Gooding I., Dondos V., Gyi K.M., et al. Variceal hemorrhage and cystic fibrosis: outcomes and implications for liver transplantation. Liver Transpl 2005, 11(12):1522-1526.
50. Paumgartner G., Beuers U. Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clin Liver Dis 2004, 8(1):67-81. vi.
51. Lindblad A., Glaumann H., Strandvik B. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease. Hepatology 1998, 27(1):166-174.
52. Colombo C., Battezzati P.M., Podda M., et al. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis. Hepatology 1996, 23(6):1484-1490.
53. Pozler O., Krajina A., Vanicek H., et al. Transjugular intrahepatic portosystemic shunt in five children with cystic fibrosis: long-term results. Hepatogastroenterology 2003, 50(52):1111-1114.
54. Mekeel K.L., Langham M.R., Gonzalez-Perralta R., et al. Combined en bloc liver pancreas transplantation for children with CF. Liver Transpl 2007, 13(3):406-409.
55. Milkiewicz P., Skiba G., Kelly D., et al. Transplantation for cystic fibrosis: outcome following early liver transplantation. J Gastroenterol Hepatol 2002, 17(2):208-213.
56. Sharp H.L. Cystic fibrosis liver disease and transplantation. J Pediatr 1995, 127(6):944-946.
57. Iannuzzi M.C., Rybicki B.A., Teirstein A.S. Sarcoidosis. N Engl J Med 2007, 357(21):2153-2165.
58. Rybicki B.A., Major M., Popovich J., et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997, 145(3):234-241.
59. Ebert E.C., Kierson M., Hagspiel K.D. Gastrointestinal and hepatic manifestations of sarcoidosis. Am J Gastroenterol 2008, 103(12):3184-3192. quiz 3193.
60. Fauci A.S., Braunwald E., Kasper D.L., et al. Harrison's principles of internal medicine 2008, McGraw-Hill, New York. 17th edition.
61. Ricker W., Clark M. Sarcoidosis; a clinicopathologic review of 300 cases, including 22 autopsies. Am J Clin Pathol 1949, 19(8):725-749.
62. Irani S.K., Dobbins W.O. Hepatic granulomas: review of 73 patients from one hospital and survey of the literature. Clin Gastroenterol 1979, 1(2):131-143.
63. Iwai K., Oka H. Sarcoidosis. Report of ten autopsy cases in Japan. Am Rev Respir Dis 1964, 90:612-622.
64. Kennedy P.T., Zakaria N., Modawi S.B., et al. Natural history of hepatic sarcoidosis and its response to treatment. Eur J Gastroenterol Hepatol 2006, 18(7):721-726.
65. Branson J.H., Park J.H. Sarcoidosis hepatic involvement: presentation of a case with fatal liver involvement; including autopsy findings and review of the evidence for sarcoid involvement of the liver as found in the literature. Ann Intern Med 1954, 40(1):111-145.
66. Warshauer D.M., Molina P.L., Hamman S.M., et al. Nodular sarcoidosis of the liver and spleen: analysis of 32 cases. Radiology 1995, 195(3):757-762.
67. Blich M., Edoute Y. Clinical manifestations of sarcoid liver disease. J Gastroenterol Hepatol 2004, 19(7):732-737.
68. Sartin J.S., Walker R.C. Granulomatous hepatitis: a retrospective review of 88 cases at the Mayo Clinic. Mayo Clin Proc 1991, 66(9):914-918.
69. Zoutman D.E., Ralph E.D., Frei J.V. Granulomatous hepatitis and fever of unknown origin. An 11 year experience of 23 cases with three years' follow-up. J Clin Gastroenterol 1991, 13(1):69-75.
70. Mino R.A., Murphy A.I., Livingstone R.G. Sarcoidosis producing portal hypertension: treatment by splenectomy and splenorenal shunt. Ann Surg 1949, 130(5):951-957.
71. Valla D., Pessegueiro-Miranda H., Degott C., et al. Hepatic sarcoidosis with portal hypertension. A report of seven cases with a review of the literature. Q J Med 1987, 63(242):531-544.
72. Rosenberg J.C. Portal hypertension complicating hepatic sarcoidosis. Surgery 1971, 69(2):294-299.
73. Moreno-Merlo F., Wanless I.R., Shimamatsu K., et al. The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis. Hepatology 1997, 26(3):554-560.
74. Russi E.W., Bansky G., Pfaltz M., et al. Budd-Chiari syndrome in sarcoidosis. Am J Gastroenterol 1986, 81(1):71-75.
75. Kelley M.L., McHardy R.J. An unusual case of fatal hepatic sarcoidosis. Am J Med 1955, 18(5):842-850.
76. Casavilla F.A., Gordon R., Wright H.I., et al. Clinical course after liver transplantation in patients with sarcoidosis. Ann Intern Med 1993, 118(11):865-866.
77. Barbers R.G. Role of transplantation (lung, liver, and heart) in sarcoidosis. Clin Chest Med 1997, 18(4):865-874.
78. Peto H.M., Pratt R.H., Harrington T.A., et al. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis 2009, 49(9):1350-1357.
79. Chong V.H. Hepatobiliary tuberculosis: a review of presentations and outcomes. South Med J 2008, 101(4):356-361.
80. Morris E. Tuberculosis of the liver. Am Rev Tuberc 1930, 22:585-592.
81. Alvarez S.Z. Hepatobiliary tuberculosis. J Gastroenterol Hepatol 1998, 13(8):833-839.
82. Rolleston H.D., McNee J.W. Diseases of the liver, gallbladder and bile ducts 1929, Macmillan, London, p. 370-81. 3rd edition.
83. Feldman M., Friedman L.S., Brandt L.J. Sleisenger and Fordtrans's gastrointestinal and liver disease 2006, Saunders, Philadelphia, p. 1731-55. 8th edition.
84. Frieden T.R., Sterling T.R., Munsiff S.S., et al. Tuberculosis. Lancet 2003, 362(9387):887-899.
85. Hersch C. Tuberculosis of the liver. A study of 200 cases. S Afr Med J 1964, 38:857-863.
86. Alvarez S.Z., Carpio R. Hepatobiliary tuberculosis. Dig Dis Sci 1983, 28(3):193-200.
87. Essop A.R., Posen J.A., Hodkinson J.H., et al. Tuberculosis hepatitis: a clinical review of 96 cases. Q J Med 1984, 53(212):465-477.
88. Maharaj B., Leary W.P., Pudifin D.J. A prospective study of hepatic tuberculosis in 41 black patients. Q J Med 1987, 63(242):517-522.
89. Maglinte D.D., Alvarez S.Z., Ng A.C., et al. Patterns of calcifications and cholangiographic findings in hepatobiliary tuberculosis. Gastrointest Radiol 1988, 13(4):331-335.
90. Fan S.T., Ng I.O., Choi T.K., et al. Tuberculosis of the bile duct: a rare cause of biliary stricture. Am J Gastroenterol 1989, 84(4):413-414.
91. Harrington P.T., Gutiérrez J.J., Ramirez-Ronda C.H., et al. Granulomatous hepatitis. Rev Infect Dis 1982, 4(3):638-655.
92. Alcantara-Payawal D.E., Matsumura M., Shiratori Y., et al. Direct detection of Mycobacterium tuberculosis using polymerase chain reaction assay among patients with hepatic granuloma. J Hepatol 1997, 27(4):620-627.